InteKrin Therapeutics, Inc.
4Patents
4Active
4Granted
45Portfolio score
Filing activity: Sep 19, 2011 → Jan 10, 2017
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9061020B2 | PPAR gamma agonists for treatment of multiple sclerosis | Human Necessities | 9 | Active |
| US9539249B2 | PPAR gamma agonists for treatment of multiple sclerosis | Human Necessities | 4 | Active |
| US9675603B2 | Solid pharmaceutical compositions of ppary modulator | Emerging Cross-Sectional Technologies | 4 | Active |
| US9867816B2 | PPARγ agonists for treatment of multiple sclerosis | Human Necessities | 4 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.